XPV
SelectiveFiled to raiseCambridge, MABiotech & pharma, Fintech, AI & machine learningLast fund filed 2025
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| XPV Fund 1Filed to raise in 2025, with no closing reported yet. | 2025 | $300M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
2 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| David Blundin | Selective | Fintech, AI & machine learning, Consumer apps & internet | 11 | 3 |
| Peter Diamandis | Quiet | Biotech & pharma, Healthcare services, Aerospace & defense | 14 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Categories of XPV’s own portfolio companies, based on 22 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of XPV’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Bold Capital | 14 | 3D SYSTEMS, Atlas Therapeutics, C19, Celularity, Celularity, Fountain Life Holdings, Foutain Health Insurance, Hyperloop Technologies, Lifeforce Digital, MK Stem Cell, Planetary Power, PLANETARY RESOURCES, Singularity Education Group, Vaxxinity |
| NeoGenesis Capital | 14 | 3D SYSTEMS, Atlas Therapeutics, C19, Celularity, Celularity, Fountain Life Holdings, Foutain Health Insurance, Hyperloop Technologies, Lifeforce Digital, MK Stem Cell, Planetary Power, PLANETARY RESOURCES, Singularity Education Group, Vaxxinity |
| Link Ventures | 11 | CLARABRIDGE, Cognius, Cogo Fund 2020, DataCebo, Datalign Advisory, Datalign Advisory, EverQuote, Farsight AI, Healthcare, SYMPHONY42, VESTMARK |
| Vestigo Ventures | 11 | CLARABRIDGE, Cognius, Cogo Fund 2020, DataCebo, Datalign Advisory, Datalign Advisory, EverQuote, Farsight AI, Healthcare, SYMPHONY42, VESTMARK |
| Space Capital (formerly Space Angels) | 2 | Planetary Power, PLANETARY RESOURCES |
| 137 Ventures | 1 | Hyperloop Technologies |
| 8VC | 1 | Hyperloop Technologies |
| Craft Ventures | 1 | Hyperloop Technologies |
| General Catalyst | 1 | CLARABRIDGE |
| M13 | 1 | Lifeforce Digital |
| S32 | 1 | Celularity |
| Serac Ventures | 1 | 3D SYSTEMS |
| Zetta Venture Partners | 1 | DataCebo |
A shared board seat: a company where filings name a XPV partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.